GlassScriptPhysician profile
Amer Alsamman
NPI 1558701540
$11,957.26
in general payments reported to CMS, 2019-2025
26 companies · $2,991 in 2025
The $2,991 reported for 2025 was more than what 87% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $911 · 2023: $4,495 · 2024: $3,396 · 2025: $2,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,976 · Food and Beverage: $3,585 · Education: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,976.19 |
| Food and Beverage | $3,585.22 |
| Education | $320.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $4,560.50 | 2022-2025 | Single Use Electrosurgical Knife Kd-655, Olympus, Disposable Distal Attachment |
| Boston Scientific Corporation | $3,320.19 | 2023-2025 | Resolution 360 Clip, Axios, Spyglass |
| Wilson Cook Medical Incorporated | $1,044.43 | 2023 | Fusion |
| Janssen Biotech, INC. | $456.17 | 2023-2025 | Stelara, Tremfya, Simponi Aria |
| Abbvie INC. | $308.36 | 2022-2025 | |
| Gilead Sciences, INC. | $275.79 | 2023-2025 | Vemlidy |
| Phathom Pharmaceuticals, INC. | $243.37 | 2024-2025 | Voquezna |
| Pfizer INC. | $221.70 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $193.89 | 2024-2025 | Entyvio, Eohilia, Gattex |
| Cook Medical LLC | $190.98 | 2021-2023 | Hemospray |
| Mallinckrodt Hospital Products INC. | $166.00 | 2023 | Terlivaz |
| Aimmune Therapeutics, INC. | $162.56 | 2024-2025 | Zenpep |
| Janssen Scientific Affairs, LLC | $152.04 | 2021-2022 | |
| Olympus America INC. | $142.04 | 2024 | Disposable Emr Kit, Single Use Electrosurgical Knife Kd-655 |
| Ardelyx, INC. | $139.93 | 2025 | Ibsrela |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Madrigal Pharmaceuticals | $59.97 | 2025 | Rezdiffra |
| Genzyme Corporation | $53.54 | 2025 | |
| Intercept Pharmaceuticals, INC. | $47.56 | 2025 | |
| Argenx US, INC. | $29.80 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Medtronic, INC. | $24.18 | 2023 | Gi Genius |
| Celgene Corporation | $21.54 | 2021 | |
| Amgen INC. | $19.82 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $18.59 | 2024 | Austedo Xr |
| Novo Nordisk INC | $16.24 | 2025 | Wegovy |
| Echosens North America, INC. | $3.07 | 2025 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Alsamman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.